US5149705A
(en)
*
|
1987-03-13 |
1992-09-22 |
Allergan, Inc. |
Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity
|
US5602130A
(en)
*
|
1987-03-20 |
1997-02-11 |
Allergan |
Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
|
US5264578A
(en)
*
|
1987-03-20 |
1993-11-23 |
Allergan, Inc. |
Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
|
US5234926A
(en)
*
|
1987-03-20 |
1993-08-10 |
Allergan, Inc. |
Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
|
US5037811A
(en)
*
|
1990-04-17 |
1991-08-06 |
Allergan, Inc. |
4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5H)-furanones as anti-inflammatory agents
|
US5134128A
(en)
*
|
1987-06-08 |
1992-07-28 |
Allergan, Inc. |
Anti-inflammatory furanones
|
US5043457A
(en)
*
|
1990-04-17 |
1991-08-27 |
Allergan, Inc. |
2(5H)-furanones substituted in the 3 position, as Ca2+ channel antagonists and anti-inflammatory agents
|
US5081147A
(en)
*
|
1990-03-15 |
1992-01-14 |
Allergan, Inc. |
4-(1-hydroxy-2-substituted amino)ethyl-5-hydroxy-2(5H)-furanones as anti-inflammatory agents
|
US5059611A
(en)
*
|
1988-11-18 |
1991-10-22 |
Allergan, Inc. |
Anti-inflammatory 5-hydroxy-2-furanones
|
US5089485A
(en)
*
|
1988-11-18 |
1992-02-18 |
Allergan, Inc. |
Anti-inflammatory furanones
|
US5171863A
(en)
*
|
1987-06-08 |
1992-12-15 |
Allergan, Inc. |
Intermediates for preparing 4-substituted 2-5(H)-furanones as anti-inflammatory agents
|
US4777288A
(en)
*
|
1987-06-11 |
1988-10-11 |
Pfizer Inc. |
Process for preparing a 4,4-diphenylbutanoic acid derivative
|
DE3737399A1
(de)
*
|
1987-11-04 |
1989-05-18 |
Schwabe Willmar Gmbh & Co |
Aminosaeureester, verfahren zu ihrer herstellung und ihre verwendung
|
AU618590B2
(en)
*
|
1988-04-11 |
1992-01-02 |
Allergan, Inc. |
Tetralin esters of phenols or benzoic acids having retinoid like activity
|
US5231113A
(en)
*
|
1988-04-11 |
1993-07-27 |
Allergan, Inc. |
Tetralin esters of phenols or benzoic acids having retinoid like activity
|
US5045564A
(en)
*
|
1988-12-07 |
1991-09-03 |
Allergan, Inc. |
Anti-inflammatory 2-furanones
|
JP2844868B2
(ja)
*
|
1989-07-20 |
1999-01-13 |
ロンザ リミテッド |
テトロン酸アルキルエステルの製造方法
|
US5399561A
(en)
*
|
1989-09-19 |
1995-03-21 |
Allergan, Inc. |
Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity
|
US5183827A
(en)
*
|
1989-09-19 |
1993-02-02 |
Allergan, Inc. |
Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
|
US5272156A
(en)
*
|
1989-09-19 |
1993-12-21 |
Allergan, Inc. |
Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
|
US5053523A
(en)
*
|
1989-09-19 |
1991-10-01 |
Allergan, Inc. |
Ethynyl-chroman compounds
|
US5248777A
(en)
*
|
1989-09-19 |
1993-09-28 |
Allergan, Inc. |
Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
|
US5162546A
(en)
*
|
1989-09-19 |
1992-11-10 |
Allergan, Inc. |
Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
|
US5112853A
(en)
*
|
1989-11-20 |
1992-05-12 |
Allergan, Inc. |
Anti-inflammatory furanone compounds
|
US5258400A
(en)
*
|
1989-11-20 |
1993-11-02 |
Allergan, Inc. |
Anti-inflammatory furanone compounds
|
US5264456A
(en)
*
|
1989-12-29 |
1993-11-23 |
Allergan, Inc. |
Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity
|
US5175185A
(en)
*
|
1989-12-29 |
1992-12-29 |
Allergan, Inc. |
Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity
|
US5202471A
(en)
*
|
1990-02-06 |
1993-04-13 |
Allergan, Inc. |
Alkyl, alkoxy and thioalkoxy substituted diphenyl acetylenes having retinoid like activity
|
US5081261A
(en)
*
|
1990-03-23 |
1992-01-14 |
Allergan, Inc. |
4-(1-hydroxy-2-N-substituted sulfonamido) ethyl-5-hydroxy-2(5H)-furanones and 4-(N-substituted sulfonamido)-2-ethenyl-5-hydroxy-2(5H)-furanones as anti-inflammatory agents
|
US5013850A
(en)
*
|
1990-03-30 |
1991-05-07 |
Allergan, Inc. |
4-ethyl and 4-ethenyl-5-hydroxy-2(5H)-furanones substituted on alpha carbon of the ethyl or ethenyl side chain with a long chain alkyl group and on the beta carbon with a polar group, as anti-inflammatory agents
|
DK0492347T3
(da)
*
|
1990-12-20 |
1997-04-01 |
Lonza Ag |
Fremgangsmåde til fremstilling af threo-4-alkoxy-5-(arylhydroxymethyl)-2(5H)-furanoner
|
JP3062248B2
(ja)
*
|
1991-02-13 |
2000-07-10 |
アラーガン、インコーポレイテッド |
レチノイド様生物学的活性を有する7位にフェニルエチニル置換基を有するクロマンおよびチオクロマン
|
US5134159A
(en)
*
|
1991-03-26 |
1992-07-28 |
Allergan, Inc. |
7-chromanyl esters of phenols and benzoic acids having retinoid-like activity
|
WO1992017471A1
(en)
*
|
1991-03-26 |
1992-10-15 |
Allergan, Inc. |
Chromans and thiochromans with heteroarylethynyl substituents at the 7-position having retinoid-like biological activity
|
US5183906A
(en)
*
|
1991-04-30 |
1993-02-02 |
Allergan, Inc. |
2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2 (5h)-furanones as anti-inflammatory agents
|
US5225571A
(en)
*
|
1991-04-30 |
1993-07-06 |
Allergan, Inc. |
Substituted dihydroxy-bis-[5-hydroxy-2(5H)-furanone-4-yl]-alkanes as anti-inflammatory agents
|
US5171864A
(en)
*
|
1991-08-30 |
1992-12-15 |
Allergan, Inc. |
Di-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega alkane-dioates and N,N-bis-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents
|
US5169963A
(en)
*
|
1991-08-30 |
1992-12-08 |
Allergan, Inc. |
Di-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega alkanedioates and N,N-bis-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents
|
US5326898A
(en)
*
|
1992-02-11 |
1994-07-05 |
Allergan, Inc. |
Substituted phenylethenyl compounds having retinoid-like biological activity
|
JP3499553B2
(ja)
*
|
1992-02-11 |
2004-02-23 |
アラーガン、インコーポレイテッド |
レチノイド様生物学的活性を有するヘテロアリール置換フェニルエテニル化合物
|
US5268387A
(en)
*
|
1992-04-24 |
1993-12-07 |
Allergan, Inc. |
Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss
|
US5324840A
(en)
*
|
1992-06-11 |
1994-06-28 |
Allergan, Inc. |
Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
|
US6492413B2
(en)
*
|
1993-01-15 |
2002-12-10 |
G.D. Searle & Co. |
3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
|
US5455265A
(en)
*
|
1993-02-11 |
1995-10-03 |
Allergan, Inc. |
Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
|
US6172115B1
(en)
|
1993-02-11 |
2001-01-09 |
Allergan Sales, Inc. |
Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
|
US5399586A
(en)
*
|
1993-03-11 |
1995-03-21 |
Allergan, Inc. |
Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity
|
US5344959A
(en)
*
|
1993-05-18 |
1994-09-06 |
Allergan, Inc. |
Tetrahydronaphthyl and cyclopropyl substituted 1,3-butadienes having retinoid-like activity
|
US5474995A
(en)
|
1993-06-24 |
1995-12-12 |
Merck Frosst Canada, Inc. |
Phenyl heterocycles as cox-2 inhibitors
|
US5475022A
(en)
*
|
1993-10-18 |
1995-12-12 |
Allergan, Inc. |
Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
|
US5470999A
(en)
*
|
1993-12-30 |
1995-11-28 |
Allergan, Inc. |
Cyclohexene and bicyclic aromatic substituted ethyne compounds having retinoid-like biological activity
|
US5426118A
(en)
*
|
1993-12-30 |
1995-06-20 |
Allergan, Inc. |
[4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
|
US5451605A
(en)
*
|
1993-12-30 |
1995-09-19 |
Allergan, Inc. |
1,2-epoxycyclohexanyl and bicyclic aromatic substituted ethyne compounds having retinoid-like biological activity
|
US5451686A
(en)
*
|
1994-04-15 |
1995-09-19 |
Allergan, Inc. |
3 and 5 alkyl and phenyl 4-(hydroxy or acyloxy)-alkyl substituted 2(5H)-furanones as anti-inflammatory agents
|
US5498755A
(en)
*
|
1994-08-23 |
1996-03-12 |
Chandraratna; Roshantha A. |
Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
|
US5543534A
(en)
*
|
1994-12-29 |
1996-08-06 |
Allergan |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
|
US5514825A
(en)
*
|
1994-12-29 |
1996-05-07 |
Allergan, Inc. |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5556996A
(en)
*
|
1994-12-29 |
1996-09-17 |
Allergan |
Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity
|
US5618931A
(en)
*
|
1994-12-29 |
1997-04-08 |
Allergan |
Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5534641A
(en)
*
|
1994-12-29 |
1996-07-09 |
Allergan |
Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
|
US5489584A
(en)
*
|
1994-12-29 |
1996-02-06 |
Allergan, Inc. |
Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5618943A
(en)
*
|
1994-12-29 |
1997-04-08 |
Allergan |
Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5648514A
(en)
|
1994-12-29 |
1997-07-15 |
Allergan |
Substituted acetylenes having retinoid-like biological activity
|
US5599967A
(en)
*
|
1994-12-29 |
1997-02-04 |
Allergan |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
|
US6025388A
(en)
|
1995-04-26 |
2000-02-15 |
Allergan Sales, Inc. |
Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
|
US5616712A
(en)
*
|
1995-05-16 |
1997-04-01 |
Allergan |
Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity
|
US5917082A
(en)
*
|
1995-06-06 |
1999-06-29 |
Allergan Sales, Inc. |
2,4-pentadienoic acid derivatives having retinoid-like biological activity
|
US5675033A
(en)
*
|
1995-06-06 |
1997-10-07 |
Allergan |
2,4-pentadienoic acid derivatives having retinoid-like biological activity
|
US6942980B1
(en)
|
1995-09-01 |
2005-09-13 |
Allergan, Inc. |
Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
|
US5958954A
(en)
*
|
1995-09-01 |
1999-09-28 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
US6218128B1
(en)
|
1997-09-12 |
2001-04-17 |
Allergan Sales, Inc. |
Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
|
US5952345A
(en)
|
1995-09-01 |
1999-09-14 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
US6008204A
(en)
|
1995-09-01 |
1999-12-28 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
AU7598596A
(en)
*
|
1995-11-01 |
1997-05-22 |
Allergan, Inc. |
Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
|
US5663357A
(en)
*
|
1995-11-22 |
1997-09-02 |
Allergan |
Substituted heteroarylamides having retinoid-like biological activity
|
US5675024A
(en)
*
|
1995-11-22 |
1997-10-07 |
Allergan |
Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
|
US5965606A
(en)
|
1995-12-29 |
1999-10-12 |
Allergan Sales, Inc. |
Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
|
US5688957A
(en)
*
|
1995-12-29 |
1997-11-18 |
Allergan |
(3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
|
US20030219832A1
(en)
*
|
1996-03-11 |
2003-11-27 |
Klein Elliott S. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
US5747542A
(en)
*
|
1996-06-21 |
1998-05-05 |
Allergan |
Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
|
US5808124A
(en)
*
|
1996-06-21 |
1998-09-15 |
Allergan |
O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US6555690B2
(en)
*
|
1996-06-21 |
2003-04-29 |
Allergan, Inc. |
Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US5773594A
(en)
|
1996-06-21 |
1998-06-30 |
Allergan |
Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US5723666A
(en)
*
|
1996-06-21 |
1998-03-03 |
Allergan |
Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US5763635A
(en)
*
|
1996-06-21 |
1998-06-09 |
Allergan |
Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
|
US5741896A
(en)
*
|
1996-06-21 |
1998-04-21 |
Allergan |
O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
GB9615867D0
(en)
*
|
1996-07-03 |
1996-09-11 |
Merck & Co Inc |
Process of preparing phenyl heterocycles useful as cox-2 inhibitors
|
US5739338A
(en)
*
|
1996-11-05 |
1998-04-14 |
Allergan |
N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
|
US5728846A
(en)
|
1996-12-12 |
1998-03-17 |
Allergan |
Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
|
US5760276A
(en)
*
|
1997-03-06 |
1998-06-02 |
Allergan |
Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
|
US6037488A
(en)
|
1997-04-19 |
2000-03-14 |
Allergan Sales, Inc. |
Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
|
US5919970A
(en)
*
|
1997-04-24 |
1999-07-06 |
Allergan Sales, Inc. |
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
|
US6756414B2
(en)
*
|
1999-07-30 |
2004-06-29 |
Sanyo Chemical Industries, Ltd. |
Polymer polyol composition, process for producing the same, and process for producing polyurethane resin
|
CN1182127C
(zh)
*
|
2000-06-28 |
2004-12-29 |
中国医学科学院药物研究所 |
新的取代的2-苯并[c]呋喃酮化合物,其制备方法以及包含它们的药物组合物
|
US6387951B1
(en)
|
2000-08-29 |
2002-05-14 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
US6369261B1
(en)
|
2000-08-29 |
2002-04-09 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
US6313107B1
(en)
|
2000-08-29 |
2001-11-06 |
Allergan Sales, Inc. |
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
|
CN1106393C
(zh)
*
|
2000-12-19 |
2003-04-23 |
中国科学院上海有机化学研究所 |
一种具有光学活性的β-芳基取代-2(5H)-呋喃酮及其合成方法
|
FR2845087B1
(fr)
*
|
2002-10-01 |
2004-12-24 |
Merck Sante Sas |
Nouveaux acides arylhexadienoiques substitues et leurs esters,utilisables dans le traitement et la prevention du diabete, des dyslipidemies,de l'atherosclerose, compositions pharmaceutiques les contenant et procedes de preparation
|